Percutaneous treatment in acute coronary syndromes

Eduardo Alegría-Barrero1, Raul Moreno

  • 1Eduardo Alegría-Barrero, Interventional Cardiology, Royal Brompton Hospital, London, SW3 6NP, United Kingdom.

Insights

Acute coronary syndromes (ACS) involve blocked coronary arteries. Treatments like drug-eluting stents and new antiplatelet agents improve outcomes by reducing restenosis and cardiac events.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Acute coronary syndromes (ACS), including ST-segment elevation myocardial infarction, stem from acute thrombotic lesions obstructing coronary blood flow.
  • Percutaneous coronary interventions aim to restore blood flow and improve clinical outcomes in ACS patients.

Purpose of the Study:

  • To review current treatment strategies for ACS.
  • To discuss recent advancements in percutaneous coronary interventions and medical therapies for ACS.

Main Methods:

  • Review of recent randomized clinical trials.
  • Analysis of advances in medical treatment, including novel antiplatelet agents.
  • Examination of updated clinical guideline recommendations for ACS management.

Main Results:

  • Bare metal stents reduced restenosis and cardiac events compared to balloon angioplasty alone.
  • Drug-eluting stents further decreased restenosis rates and clinical events.
  • New antiplatelet agents and updated guidelines offer improved therapeutic options.

Conclusions:

  • Percutaneous treatment, particularly with drug-eluting stents, has significantly improved ACS outcomes.
  • Ongoing research and evolving medical treatments, including new antiplatelet therapies, continue to refine ACS management.
  • Adherence to recent guideline recommendations is crucial for optimal patient care in ACS.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...